Document is current
Any future updates will be listed below
-
Authors
Usui-Ouchi, Ayumi https://orcid.org/0000-0003-2974-0830
Kishishita, Shuta
Sakanishi, Yoshihito
Mashimo, Keitaro
Tamaki, Kazunori
Matsuzawa, Moe
Kimura, Meiko
Ikari, Riyu
Morita, Shuu
Ninomiya, Ishin
Sakuma, Toshiro
Ebihara, Nobuyuki
Nakao, Shintaro
-
Funding
Funding for this research was provided by:
JSPS KAKENHI (22KK0291)
Japan Vitreoretinal Society
- License Information
-
More Information
Article History
Received: 30 May 2024
Accepted: 8 December 2024
First Online: 28 February 2025
Declarations
:
: A. U-Ouchi, Grants or contracts (Bayer), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Bayer, Chugai, Santen, Senju, Novartis); S. Kishishita, None; Y. Sakanishi, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Bayer, Chugai, Santen, Senju, Novartis); K. Mashimo, None; K.Tamaki, None; M. Matsuzawa, None; M. Kimura, None; R. Ikari, None; S. Morita, None; I. Ninomiya, None; T. Sakuma, None; N. Ebihara, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Senju); S. Nakao, Grants or contracts (Alcon, Otsuka, HANDAYA, Santen, HOYA, Seed, IWAKI OPTICAL, Senju, JFC Sales Plan, TOMEY, Kowa, WAKAMOTO), Consulting fees (Alcon, Boehringer Ingelheim, Bayer, Novartis, Chugai, RIVERFIELD, Kowa, Senju), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Alcon, Boehringer Ingelheim, Bayer, Novartis, Chugai, Novo Nordisk, JFC Sales Plan, Otsuka, Johnson & Johnson, Santen, Kowa, Senju, Machida Endoscope, WAKAMOTO, Mitsubishi Tanabe Pharma), Support for attending meetings and/or travel (Chugai, Novartis, NIPRO, Sumitomo), Patents planned, issued or pending (RIVERFIELD).
